Allergenis
Growth Stage
The Next Generation of Food Allergy Testing
Overview
Raised: $359,714
Total Commitments ($USD)
Platform
StartEngine
Start Date
04/24/2023
Close Date
07/20/2023
Min. Goal
$10,000
Max. Goal
$1,235,000
Min. Investment
$250
Security Type
Equity - Common
Series
Series B
SEC Filing Type
RegCF
Price Per Share
$5.00
Pre-Money Valuation
$40,000,005
Rolling Commitments ($USD)
Status
Active
Reporting Date
06/10/2023
Days Remaining
40
% of Min. Goal
3,597%
% of Max. Goal
29%
Likelihood of Max
Avg. Daily Raise
$7,653
# of Investors
189
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B/B2C
Margin
High
Capital Intensity
Low
Allergenis, with a valuation of $40 million, is raising funds on StartEngine. The company uses cutting-edge systems biology and data analytics to provide next-generation food allergy testing. The Allergenis system of testing determines tolerance levels, allergic status, and reaction severity to provide a better-informed quality of life. Currently, Allergenis provides peanut allergic status and threshold testing in 49 states and Washington, DC, and plans to launch milk allergy testing in 2023 and egg allergy testing in 2024. Jim Garner founded Allergenis in September 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1.24 million. The campaign proceeds will be used for sales and marketing, clinical operations, research and development, and general and administrative expenses.
Summary Profit and Loss Statement
| FY 2022 | FY 2021 | |
|---|---|---|
|
Revenue |
$74,140 |
$269,597 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-4,952,594 |
$-3,422,933 |
Summary Balance Sheet
| FY 2022 | FY 2021 | |
|---|---|---|
|
Cash |
$31,203 |
$19,639 |
|
Accounts Receivable |
$4,395 |
$10,000 |
|
Total Assets |
$454,522 |
$368,099 |
|
Short-Term Debt |
$5,157,434 |
$1,496,119 |
|
Long-Term Debt |
$1,050,000 |
$2,942,000 |
|
Total Liabilities |
$6,207,434 |
$4,438,119 |
Financials as of: 04/24/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
